Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis

By Chrysant Steven G.   Murray Alexander V.   Hoppe Uta C.   Dattani Dan   Patel Samir   Hsu Huang   Zhang Jack  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1039-1047

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension

By Littlejohn Thomas W.   Trenkwalder Peter   Hollanders Geert   Zhao Yanxing   Liao Weichi  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 951-959

Informa Healthcare

Access to resources Recommend Favorite

Long-term tolerability and efficacy of the combination of amlodipine/valsartan in hypertensive patients: a 54-week, open-label extension study*

By Philipp Thomas   Glazer Robert D.   Zhao Yanxing   Pospiech Rainer  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 187-193

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy

By Farnier Michel   Ducobu Jean   Bryniarski Leszek  

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2165-2173

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension

By  

Respiration, Vol. 89, Iss. 6, 2015-06 ,pp. : 515-524

Karger

Access to resources Recommend Favorite